ETF Research for Superhero Investors: Six Panel Perspectives

Superhero lowered the friction and minimum investment for younger Australians entering the market. Lower friction does not reduce the need for independent, multi-lens research on the US ETFs you choose — that is what Cognitor provides every Friday.

Superhero → Cognitor → YouExecution stays at Superhero. Research: six Panel lenses, five SENIOR verdicts, PRIME — each week the methodology assesses the macro scenario against the same ~40 curated US-listed ETFs, then the dossier deep-dives those selected for that edition (theses, validations, invalidations)—not a full standalone report on every ticker every Friday.

Friction is down — depth still matters

Superhero made it easier than ever for younger Australians to open an account and start building a portfolio. It does not supply six independent specialist analyses and five SENIOR verdict layers deliberating on the same ETF materials every week — with PRIME showing where the macro and valuation story is stable versus contested. That is Cognitor's weekly process.
  • Lower entry barriers mean more investors adding US ETF exposure without a corresponding increase in research depth — Cognitor addresses that gap directly.
  • For Superhero users buying US-listed ETFs, AUD/USD exchange rate exposure is part of every position: HELIOS and VEGA lenses address the macro and FX conditions driving that risk.
  • Australian CGT applies when you sell US ETFs held via Superhero — structured macro context from Cognitor can support the decision-making process around timing, though all tax decisions belong to your adviser.
Validation mindset — structured research next to your brokerage execution

ETFs in the Cognitor universe

The fixed universe is ~40 curated US-listed ETFs—not the whole market. Each weekly dossier focuses on the subset selected for that week's scenario (deep research with theses, validations, and invalidations). The Panel still grounds the process in the full universe scan. Below are examples Superhero investors often hold or can map from their menu; each card opens that ticker's overview page. Inclusion is informational, not a buy or sell recommendation.

Superhero users skew toward growth and thematic ETFs (QQQ, SMH, IBIT). NEXUS (tech + AI cycles) and PSYCHE (behavioral + positioning) lenses are most immediately relevant for those sleeves, addressing the narrative and momentum dynamics that drive high-beta US ETFs.

How it fits your workflow

  1. Step 1Before tapping buy on a thematic ETF, scan the latest Friday dossier if that ticker is covered.
  2. Step 2Treat SENIOR splits as risk information, not entertainment — documented disagreement is part of the research value.
  3. Step 3Execute in Superhero under your own rules and risk limits.
Research at Cognitor, execution at your broker — connected workflow

Start free. Upgrade when it matters.

Free tier follows the same cadence with delays; Pro unlocks same-week dossiers, briefings, and Mon–Thu daily podcasts. About AU$ 5.95/month with the current offer after a 7-day trial.

At checkout, Stripe shows the exact amount and currency for your billing country — no surprises.

Free

$0

  • Full dossier on a 7-day delay; briefings after 24h vs Pro same-day
  • Great way to explore the Panel → SENIOR → PRIME workflow
Create free account

Pro

7-day trialMost popular

US$9.90 / month

US$4.95 / month

  • Weekly dossier deep-diving the ETFs selected for that week from ~40 US-listed names
  • Same-week briefings and Mon–Thu daily podcasts
  • Cancel anytime
Start Pro trial

Full plan comparison →

Transparency — research layer only; execution and custody stay at your broker

Common questions

Australian investors: how Cognitor complements Superhero without custody or order flow.

  • No. There is no account linking, no portfolio sync, and no data shared between Cognitor and Superhero. You read the research here and execute independently on Superhero.